
Beyond providing clinical services to cover a wide spectrum of urological conditions, the department also has strong endeavors in research, contributing to the body of knowledge in the field. This comprises of several grant-supported clinical trials as well as research harnessing the strengths of our robust prospectively maintained cancer registry and database.
Current ongoing clinical trials:
- Multi-Cancer Early Detection (MCED) Study - Clinical study evaluating accuracy and reliability of urine test to diagnose early kidney, bladder, and prostate cancer
- FLAME-PC (Focal therapy or radical therapy: Lesion-based Molecular Evaluation in Prostate Cancer)
- Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
- A Prognostic and Predictive Clinical-Molecular Signature for Risk-stratification of Localized Prostate Cancer
- Evaluating functional and oncological outcomes of Focal Cryotherapy for Prostate Cancer using a Novel MRI-US fusion robotic platform: A Prospective Study
- WeeCare – Creation of a novel device for personalized assessment of patients with lower urinary tract symptoms (LUTS)
- Management of Detrusor-overactivity with Detrusor-underactivity (DO-DU) via Stimulation of the Tibial nerve – the MODEST pilot study
- Targeting pressure transmission to the bladder in stress urinary incontinence.
- MV140 Vaccine for Prevention of Urinary Tract Infections in the Presence of a Foreign Body
- Analysis of Bladder Imaging Software for Overactive bladder
- Creation of a novel Audio Uroflow App for use with a smart phone for the assessment of patients with lower urinary tract symptoms
- Generation of bladder cancer PDX in humanized mice and its use in drug testing
- A non-interventional study of efficacy and utility of BC101 urine test for diagnosis of urothelial cancer
- Development and Validation of Novel Point of Care Urine Biochemistry Device to Optimize Management of Nocturia
- AI in Cytopathology of Bladder Cancer
Recent department publications:
- Impact of magnetic resonance imaging-based diagnostic pathway on oncologic outcomes of localised prostate cancer between primary treatment modalities: a Will-Rogers phenomenon?
World Journal of Urology, October 2026
https://pubmed.ncbi.nlm.nih.gov/42828553/
- Gut Microbiome Composition and Oxalate-Related Metabolic Functions in Staghorn Calcium Oxalate Stone Formers: A Shotgun Metagenomic Analysis
Research Square, October 2026
https://doi.org/10.21203/rs.3.rs-9372902/v1
- Adjustable tension ligation with anterior suspension (ATLAS) suture of the dorsal venous complex in robotic-assisted radical prostatectomy
Urology Video Journal, September 2026
https://doi.org/10.1016/j.urolvj.2026.100422
- From Evaluation to Implementation: A Delphi Consensus Framework with Domain-Weighted Decision Models for Robotic Surgery Adoption
Healthcare, August 2026
https://pubmed.ncbi.nlm.nih.gov/42651406/
- Thulium fiber laser versus high-power holmium laser for renal stones: a systematic review and meta-analysis of high-quality studies
Therapeutic Advances in Urology, August 2026
https://pubmed.ncbi.nlm.nih.gov/42630426/
- Retrograde intrarenal surgery with flexible and navigable suction access sheaths vs mini-percutaneous nephrolithotomy for large upper urinary tract stones: a systematic review and meta-analysis
BJU International, July 2026
https://pubmed.ncbi.nlm.nih.gov/42527043/